John Poyhonen
2020 - Heron Therapeutics
Compensation breakdown
| Non-Equity Incentive Plan | $197,960 |
|---|---|
| Option Awards | $1,635,349 |
| Salary | $513,935 |
| Stock Awards | $314,400 |
| Other | $8,550 |
| Total | $2,670,194 |
Poyhonen received $1.6M in option awards, accounting for 61% of the total pay in 2020.
Poyhonen also received $198K in non-equity incentive plan, $513.9K in salary, $314.4K in stock awards and $8.6K in other compensation.
Rankings
In 2020, John Poyhonen's compensation ranked 4,299th out of 13,090 executives tracked by ExecPay. In other words, Poyhonen earned more than 67.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,299 out of 13,090 | 67th |
Division Manufacturing | 1,738 out of 5,620 | 69th |
Major group Chemicals And Allied Products | 678 out of 2,253 | 70th |
Industry group Drugs | 579 out of 1,953 | 70th |
Industry Pharmaceutical Preparations | 440 out of 1,458 | 70th |
Pay ratio
| John Poyhonen's Pay | $2,670,194 |
|---|---|
| Median Employee's Pay | $363,920 |
| Pay Ratio | 7to 1 |
In 2020, the annual total compensation of John Poyhonen was $2,670,194.
The annual total compensation of the median employee at Heron Therapeutics was $363,920.
The ratio of John Poyhonen's pay to the pay of median employee was therefore 7 to one.
Poyhonen's colleagues
We found five more compensation records of executives who worked with John Poyhonen at Heron Therapeutics in 2020.
2020
Barry Quart
Heron Therapeutics
Chief Executive Officer
2020
David Szekeres
Heron Therapeutics
Chief Operating Officer
2020
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
2020
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
2020
Robert Hoffman
Heron Therapeutics